Showing results (1-10 of 136) with videos related to
Sort By:
Pageof 14
Expert Opinion on Investigational Drugs|October 10, 2007
The therapeutic potential of O6-alkylguanine DNA alkyltransferase inhibitorsOmar Khan, Mark R MiddletonAmerican Journal of Clinical Dermatology|April 1, 2022
Long-Term Outcomes of Immune Checkpoint Inhibition in Metastatic MelanomaFrancesca Aroldi, Mark R MiddletonCancer Treatment Reviews|November 22, 2005
The emerging role of DNA repair proteins as predictive, prognostic and therapeutic targets in cancerSrinivasan Madhusudan, Mark R MiddletonCurrent Opinion in Pharmacology|June 17, 2006
Exploiting the role of O6-methylguanine-DNA-methyltransferase (MGMT) in cancer therapyAmi Sabharwal, Mark R MiddletonImmunotherapy Advances|August 21, 2023
Combination therapies for the optimisation of Bispecific T-cell Engagers in cancer treatmentWinston M Zhu, Mark R MiddletonThe Lancet. Oncology|January 9, 2003
Improvement of chemotherapy efficacy by inactivation of a DNA-repair pathwayMark R Middleton, Geoffrey P MargisonAnti-Cancer Drugs|May 29, 2004
DNA repair pathways in drug resistance in melanomaPenny A Bradbury, Mark R MiddletonSeminars in Oncology|October 31, 2002
Brain metastases in melanoma: a European perspectiveEmma Cattell, Charles Kelly, Mark R MiddletonUnited European Gastroenterology Journal|August 19, 2016
Genetic susceptibility to Barrett's oesophagus: Lessons from early studiesJohn M Findlay, Mark R Middleton, Ian TomlinsonDigestive Diseases and Sciences|October 9, 2015
Genetic Biomarkers of Barrett's Esophagus Susceptibility and Progression to Dysplasia and Cancer: A Systematic Review and Meta-AnalysisJohn M Findlay, Mark R Middleton, Ian TomlinsonPageof 14